Ubiquitination and SUMOylation effects on proteasome activity in MM
Ubiquitination and SUMOylation effects on proteasome activity in multiple myeloma cell lines (MM). This projects includes two cell line: OPM2 and MM1s. Those cells are treated with a SUMOylation inhibitor (TAK-981) and a ubiquitine inhibitor (TAK-243). The results of RNA-seq are published here